These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3102568)

  • 1. Xanthogranulomatosis in an adult: lipid analysis of xanthomas and plasma.
    Garvey WT; Grundy SM; Eckel R
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 2):183-7. PubMed ID: 3102568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters.
    Bhattacharyya AK; Connor WE
    J Clin Invest; 1974 Apr; 53(4):1033-43. PubMed ID: 4360855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrotendinous xanthomatosis: A cause of cataracts and tendon xanthoma.
    Swartz M; Burman KD; Salen G
    Am J Med Sci; 1982; 283(3):147-52. PubMed ID: 6805326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normolipemic tendon and tuberous xanthomas.
    Fleischmajer R; Tint GS; Bennett HD
    J Am Acad Dermatol; 1981 Sep; 5(3):290-6. PubMed ID: 7263974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
    Nockowski P; Woźniak Z; Reich A; Maj J
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study.
    Parker F; Bagdade JD; Odland GF; Bierman EL
    J Clin Invest; 1970 Dec; 49(12):2172-87. PubMed ID: 5480845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric reticulohistiocytosis, another lipid disorder with normolipidemic xanthomatosis?
    Kesäniemi YA; Ehnholm C; Miettinen TA
    Atherosclerosis; 1987 Dec; 68(3):179-89. PubMed ID: 3426652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normolipemic subcutaneous xanthomatosis.
    Fleischmajer R; Schaefer EJ; Gal AE; Pentchev PG; Tint GS
    Am J Med; 1983 Dec; 75(6):1065-70. PubMed ID: 6650539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins.
    Patsch W; Brown SA; Gotto AM; Young RL
    Am J Obstet Gynecol; 1989 Nov; 161(5):1396-401. PubMed ID: 2686455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.